ARCHIVES

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Committee Approves Concepts For Studies In Special Populations

December 11, 1987

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994